Hemorheological
Introduction
Section titled “Introduction”Background
Section titled “Background”Hemorheology is the scientific study of the flow and deformation properties of blood. It encompasses the physical characteristics of blood and its components, and how these properties influence blood circulation throughout the cardiovascular system. Understanding hemorheological principles is crucial for comprehending the mechanics of blood flow, oxygen and nutrient delivery to tissues, and the removal of waste products. Key aspects of hemorheology include blood viscosity, red blood cell deformability, platelet aggregation, and plasma viscosity.
Biological Basis
Section titled “Biological Basis”The biological basis of hemorheology lies in the intricate interplay between the cellular and fluid components of blood and the physical forces within blood vessels. Red blood cells, which constitute the majority of blood volume, possess remarkable flexibility, allowing them to deform and pass through capillaries narrower than their own diameter. The ability of these cells to deform, along with their tendency to aggregate (rouleaux formation), significantly influences blood viscosity. Plasma, the liquid component of blood, contributes to viscosity primarily through its protein content, such as fibrinogen and globulins. Genetic factors can influence the structure and function of red blood cells, plasma proteins, and components involved in platelet activity, thereby affecting an individual’s hemorheological profile.
Clinical Relevance
Section titled “Clinical Relevance”Hemorheological properties have profound clinical relevance, as alterations in blood flow characteristics are implicated in the development and progression of numerous diseases. Increased blood viscosity or reduced red blood cell deformability can impede blood flow, leading to conditions such as hypertension, atherosclerosis, and an elevated risk of thrombotic events like stroke and heart attack. Diabetes, peripheral artery disease, and certain inflammatory conditions are also associated with abnormal hemorheology. Monitoring hemorheological parameters can aid in disease diagnosis, prognosis, and the assessment of treatment efficacy, offering insights beyond traditional risk factors.
Social Importance
Section titled “Social Importance”The social importance of hemorheology stems from its broad implications for public health and disease prevention. Given its links to prevalent chronic diseases like cardiovascular disease and diabetes, understanding individual hemorheological profiles could contribute to personalized medicine approaches. By identifying individuals at higher risk based on their genetic predispositions and unique blood flow characteristics, interventions can be tailored to improve circulatory health. This could lead to better disease management, improved quality of life, and a reduction in the significant healthcare burden associated with these conditions.
Limitations
Section titled “Limitations”Research into hemorheological traits, while advancing our understanding, is subject to several important limitations that impact the interpretation and generalizability of findings. These constraints span methodological approaches, the inherent complexity of genetic and phenotypic factors, and the pervasive influence of environmental elements.
Methodological and Statistical Challenges
Section titled “Methodological and Statistical Challenges”Studies on hemorheological often face limitations related to their design and statistical power. Many investigations rely on relatively small sample sizes, which can diminish the statistical power required to detect true associations and may lead to an overestimation of effect sizes for identified genetic variants. This constraint makes it challenging to confidently extrapolate findings to broader populations and contributes to gaps in replication, where initial associations fail to consistently appear in independent cohorts. Such inconsistencies raise concerns about potential false positives and the overall robustness of reported genetic markers, necessitating larger, well-powered studies for validation.
Genetic and Phenotypic Complexity
Section titled “Genetic and Phenotypic Complexity”The generalizability of findings in hemorheological research is often restricted by cohort biases, with a predominant focus on populations of European ancestry. This limits the applicability of genetic insights to diverse populations, which may possess distinct genetic architectures and linkage disequilibrium patterns, making identified variants less relevant or effective in other ethnic groups. Furthermore, hemorheological traits are complex phenotypes whose precise quantification can vary significantly across studies due to differing methodologies, laboratory protocols, and instrumentation. This variability introduces measurement noise that can obscure genuine genetic signals and complicate the integration of data from multiple studies. Despite ongoing research, a significant portion of the heritability for these traits remains unexplained, pointing to “missing heritability” that likely arises from undiscovered rare variants, intricate gene-gene interactions, or epigenetic mechanisms, thus hindering a comprehensive understanding of their genetic underpinnings.
Environmental and Gene-Environment Interactions
Section titled “Environmental and Gene-Environment Interactions”Hemorheological traits are profoundly influenced by a multitude of environmental factors, including lifestyle choices such as diet, physical activity, and smoking, as well as various medications and co-existing health conditions. These potent non-genetic confounders can significantly modulate or even mask underlying genetic associations, making it arduous to isolate and accurately attribute effects solely to genetic predispositions. Moreover, the intricate interplay between an individual’s genetic makeup and their specific environmental exposures—known as gene-environment interactions—is often under-explored but crucial; particular genetic variants may only manifest their effects, or exhibit altered magnitudes, under specific environmental contexts, underscoring the necessity for more sophisticated research designs capable of capturing these complex interactions to fully elucidate the etiology of hemorheological variation.
Variants
Section titled “Variants”Genetic variations play a significant role in modulating biological processes that underpin hemorheological traits, influencing blood viscosity, red blood cell deformability, and vascular function. Several single nucleotide polymorphisms (SNPs) are associated with genes involved in diverse cellular mechanisms, from RNA regulation to protein signaling and cell adhesion. For instance,rs11661911 is located near GTSCR1, also known as LINC01541, a long intergenic non-coding RNA (lincRNA) that can regulate gene expression by interacting with DNA, RNA, or proteins. [1] Such regulatory RNAs are crucial for maintaining cellular homeostasis, and alterations could impact the development or function of blood components or the vascular endothelium, thereby affecting blood flow properties. [1] Similarly, rs745439 is associated with LINC02841, another lincRNA whose regulatory effects might influence pathways relevant to inflammation or cellular proliferation within the circulatory system.
Further impacting cellular regulation, rs28371438 is found within EPCIP-AS1, an antisense RNA that can modulate the expression of its sense gene, EPCIP (Endothelial Cell-Specific Protein, C-terminal Interacting Protein), which is involved in endothelial cell function and angiogenesis . Variations in this region could alter EPCIP levels, potentially affecting vascular integrity and the dynamic properties of blood vessels, which are critical determinants of hemorheology. The pseudogene-associated variant rs2410367 , linked to PPM1AP1 and RPL32P19, might influence gene expression through regulatory interactions, as pseudogenes are increasingly recognized for their roles in modulating the expression of their functional parent genes or other related transcripts. [1] Meanwhile, the variant rs4689231 in STK32B, a serine/threonine kinase, could affect signal transduction pathways vital for cellular growth, metabolism, and stress responses, potentially influencing the properties of blood cells or endothelial cells.[1]
The complex interplay of cell adhesion, development, and signaling is also influenced by other variants. rs10977588 is associated with PTPRD, a receptor-type protein tyrosine phosphatase critical for cell adhesion, neuronal development, and tumor suppression. [1] Dysregulation of PTPRD could impact cell-cell interactions within the vascular system or affect the structural integrity of blood vessel walls, influencing blood flow dynamics. The variant rs34469348 in LSAMP(Limbic System-Associated Membrane Protein), a neuronal cell adhesion molecule, might indirectly influence hemorheology by affecting neurological pathways that regulate systemic responses to stress, which can alter cardiovascular parameters.[1] Additionally, rs117580912 is found within NRXN1-DT, a delta transcript of NRXN1, a gene primarily known for its role in synapse formation; however, neurexins can also mediate cell adhesion in non-neuronal contexts, potentially impacting endothelial cell interactions or vessel wall integrity. Furthermore, rs9361295 in MEI4, a gene involved in meiotic recombination, and rs1297329 in MIR99AHG, the host gene for miR-99a, represent broader genetic influences; miR-99a is known to regulate processes such as inflammation and angiogenesis, which are directly relevant to vascular health and blood properties. [1]
Key Variants
Section titled “Key Variants”Classification, Definition, and Terminology
Section titled “Classification, Definition, and Terminology”Defining Hemorheology: Concepts and Core Terminology
Section titled “Defining Hemorheology: Concepts and Core Terminology”The term ‘hemorheological’ refers to the properties and behaviors related to hemorheology, which is the scientific study of the flow and deformation of blood and its components. This field investigates how blood’s physical characteristics, such as its viscosity, influence circulation and overall cardiovascular function. Key conceptual frameworks within hemorheology emphasize blood as a non-Newtonian fluid, meaning its viscosity changes with shear rate, and its intricate composition of plasma, red blood cells, white blood cells, and platelets dictates its rheological behavior. Understanding these properties is crucial for comprehending normal physiological processes and the pathophysiology of various diseases.
Core terminology in hemorheology includes blood viscosity, which is a measure of blood’s resistance to flow, and plasma viscosity, specifically referring to the resistance of the fluid component of blood. Additionally, red blood cell deformability, the ability of red blood cells to change shape to navigate narrow capillaries, is a critical hemorheological parameter.[2] Other important terms encompass red blood cell aggregation, the tendency of red blood cells to clump together, and platelet aggregability, which describes the propensity of platelets to form clots. [3]These interconnected properties collectively define the hemorheological profile of an individual and are fundamental to understanding blood flow dynamics.
Operational Definitions and Measurement of Hemorheological Parameters
Section titled “Operational Definitions and Measurement of Hemorheological Parameters”Operational definitions for hemorheological parameters specify the methods by which these properties are measured, providing a basis for both clinical assessment and research. Blood viscosity, for instance, is typically measured using viscometers, which quantify resistance to flow at various shear rates, often expressed in centipoise (cP) or Pascal-seconds (Pa·s).[4]Red blood cell deformability is commonly assessed through techniques such as ektacytometry, which measures the elongation index of red blood cells under controlled shear stress, or via filtration methods that determine the time required for red blood cells to pass through pores of a specific size.[5]These measurement approaches establish quantifiable metrics that serve as diagnostic and research criteria, allowing for the comparison of hemorheological states across different populations or conditions.
Diagnostic and measurement criteria in hemorheology often involve establishing thresholds or cut-off values for these parameters to identify abnormal states. For example, elevated blood viscosity beyond certain thresholds can indicate a hyperviscosity syndrome, which may be associated with various clinical conditions. [6]Research criteria may employ more nuanced or specific measurement protocols to explore subtle changes in hemorheological properties in response to interventions or disease progression. While specific biomarkers directly representing hemorheological properties are not typically used in the same vein as biochemical markers, the measured parameters themselves (e.g., whole blood viscosity, red blood cell deformability index) function as direct indicators for assessing hemorheological status.
Classification of Hemorheological Conditions and Clinical Relevance
Section titled “Classification of Hemorheological Conditions and Clinical Relevance”Hemorheological conditions are primarily classified based on deviations from normal ranges of key parameters, often leading to either hyperviscosity or hypoviscosity states, though the latter is less commonly a primary clinical concern. Hyperviscosity syndromes, characterized by abnormally high blood viscosity, can be further categorized by their underlying causes, such as increased plasma protein concentration (e.g., in Waldenström’s macroglobulinemia or multiple myeloma), elevated red blood cell count (e.g., polycythemia vera), or reduced red blood cell deformability (e.g., sickle cell disease).[7] These classifications help guide diagnostic investigations and therapeutic strategies, which often aim to normalize blood viscosity or improve specific rheological properties.
The clinical significance of hemorheological alterations spans numerous disease classifications, including cardiovascular diseases, diabetes mellitus, and inflammatory conditions. For instance, increased blood viscosity is recognized as an independent risk factor for cardiovascular events, contributing to impaired microcirculation, reduced tissue perfusion, and increased cardiac workload.[8]Severity gradations of hemorheological abnormalities are often linked to the extent of deviation from physiological norms and their correlation with clinical symptoms or disease progression. While some conditions present clear categorical diagnoses, the assessment of hemorheological risk often involves a more dimensional approach, considering a spectrum of values rather than strict binary categories.
Biological Background
Section titled “Biological Background”Cellular and Molecular Determinants of Blood Flow
Section titled “Cellular and Molecular Determinants of Blood Flow”The intricate properties of blood flow, known as hemorheology, are fundamentally governed by the molecular composition and cellular characteristics of blood. Red blood cell (RBC) deformability is a critical factor, allowing these cells to navigate narrow capillaries much smaller than their diameter; this flexibility is largely maintained by the cytoskeleton, a complex network of proteins like spectrin, ankyrin, and band 3 protein, which allow the cell membrane to stretch and recover its shape without lysis. [2] Plasma viscosity, another key determinant, is primarily influenced by the concentration and nature of large plasma proteins, with fibrinogen and albumin being particularly significant contributors. Elevated levels of these proteins can increase the internal friction of blood, thereby impeding its flow through the circulatory system.
Beyond individual cell properties, the interactions between blood components also dictate flow dynamics. Platelet aggregation and adhesion, mediated by specific receptors such as GPIIb/IIIaand signaling pathways involving thromboxane A2, can lead to the formation of microthrombi, significantly increasing local blood viscosity and resistance to flow. Furthermore, the endothelium, the inner lining of blood vessels, plays a crucial role by releasing vasoactive substances like nitric oxide and prostacyclin, which influence vessel diameter and modulate the shear stress experienced by blood, thereby indirectly affecting hemorheological properties. Disruptions in these molecular and cellular functions can lead to altered blood viscosity, impacting the efficiency of oxygen and nutrient delivery to tissues.
Genetic and Epigenetic Regulation of Hemorheology
Section titled “Genetic and Epigenetic Regulation of Hemorheology”Genetic mechanisms exert a substantial influence on the baseline hemorheological profile of an individual by regulating the expression and function of key biomolecules. Genes likeANK1 and SPTA1 encode critical components of the red blood cell cytoskeleton, and variations within these genes can affect RBC deformability, directly impacting blood viscosity. Similarly, genetic polymorphisms in genes such as FGB, which codes for fibrinogen, or ALB, which codes for albumin, can lead to altered plasma protein concentrations, subsequently modifying plasma viscosity. [1]
Beyond direct gene coding, regulatory elements and epigenetic modifications, such as DNA methylation or histone acetylation, can modulate the expression patterns of genes involved in hemorheology. For instance, epigenetic changes might influence the production of endothelial factors like nitric oxide synthase, encoded byNOS3, thereby affecting vascular tone and peripheral resistance to blood flow. These genetic and epigenetic variations contribute to the inter-individual variability in hemorheological parameters, providing a foundation for understanding susceptibility to conditions associated with altered blood flow.
Microvascular Dynamics and Tissue Perfusion
Section titled “Microvascular Dynamics and Tissue Perfusion”At the tissue and organ level, hemorheological properties are critical for maintaining adequate microcirculation and ensuring efficient tissue perfusion. The viscosity of blood directly influences the pressure required to perfuse capillary beds, where oxygen and nutrient exchange occur; higher viscosity necessitates greater cardiac work to maintain adequate flow. Organ-specific effects are evident, with the heart needing to pump harder to overcome resistance in the systemic circulation, and organs like the kidneys experiencing altered filtration rates due to changes in blood flow dynamics.[9]
Systemic consequences of altered hemorheology include impacts on blood pressure regulation and the immune response, as the movement of immune cells through the vasculature is also affected by blood viscosity. Interactions between blood components and the vascular endothelium are constant, with shear stress from flowing blood influencing endothelial cell function and gene expression, which in turn can modulate vessel diameter and surface properties. These complex interactions highlight how systemic hemorheological changes can have widespread effects across various organ systems, influencing overall physiological function and contributing to disease pathogenesis.
Pathophysiological Implications of Altered Hemorheology
Section titled “Pathophysiological Implications of Altered Hemorheology”The maintenance of optimal hemorheological properties is essential for homeostasis, and disruptions can initiate or exacerbate various pathophysiological processes. Conditions such as diabetes mellitus, hypertension, and hyperlipidemia are often associated with increased blood viscosity due to factors like elevated plasma glucose, fibrinogen, or LDL cholesterol, respectively.[10] This increased viscosity can lead to reduced tissue perfusion, contributing to ischemia and organ damage in susceptible areas like the retina, kidneys, and peripheral limbs.
In the context of disease mechanisms, altered hemorheology contributes to the pathogenesis of cardiovascular diseases by promoting endothelial dysfunction, accelerating atherosclerosis, and increasing the risk of thrombotic events. For example, increased blood viscosity can enhance platelet adhesion and aggregation, predisposing individuals to myocardial infarction or stroke. While the body possesses compensatory responses, such as vasodilation to reduce resistance, chronic hemorheological disturbances can overwhelm these mechanisms, leading to progressive tissue damage and worsening disease outcomes.
Cellular and Molecular Regulation of Blood Viscosity
Section titled “Cellular and Molecular Regulation of Blood Viscosity”The flow properties of blood, collectively known as hemorheology, are intricately regulated at the cellular and molecular levels, primarily impacting red blood cell (RBC) deformability, aggregation, and plasma viscosity. Signaling pathways within RBCs and endothelial cells play a crucial role, as receptor activation can trigger intracellular cascades that modify cytoskeletal components or membrane protein function. For instance, nitric oxide signaling, often initiated by endothelial cells, can influence vasodilation and directly enhance RBC deformability, thereby reducing blood viscosity and improving microcirculatory flow. These cellular responses are often subject to feedback loops, ensuring dynamic adjustments to maintain optimal blood flow.
Regulatory mechanisms further fine-tune these properties through gene regulation and post-translational modifications. Genes encoding proteins vital for RBC membrane integrity and flexibility, such as spectrin and ankyrin, are precisely regulated to maintain the cell’s biconcave shape and capacity to deform under shear stress. Post-translational modifications, including phosphorylation and glycosylation of membrane proteins, can alter their functional state, affecting RBC-RBC interactions and their susceptibility to aggregation. These molecular adjustments are critical for blood’s ability to navigate the complex vascular network without impediment.
Metabolic Pathways Influencing Erythrocyte Function
Section titled “Metabolic Pathways Influencing Erythrocyte Function”Metabolic pathways within red blood cells are fundamental to maintaining their hemorheological properties, particularly their deformability. Glycolysis is the primary energy-producing pathway in mature erythrocytes, generating adenosine triphosphate (ATP) essential for active membrane pumps, such as the sodium-potassium ATPase, which maintain cellular volume and osmotic balance. Adequate ATP levels are crucial for the integrity of the RBC cytoskeleton and membrane, directly impacting the cell’s ability to deform and pass through narrow capillaries. The pentose phosphate pathway also plays a vital role by producing NADPH, which is necessary for reducing oxidative stress and protecting hemoglobin and membrane proteins from damage, thereby preserving RBC flexibility.
The regulation of metabolic flux within these pathways is tightly controlled to meet the energy demands of the RBC and manage oxidative challenges. Enzymes like hexokinase and phosphofructokinase, key regulators of glycolysis, are subject to allosteric control, allowing rapid adjustments to metabolic rates based on cellular needs and substrate availability. This metabolic regulation ensures a continuous supply of energy and reducing equivalents, which are indispensable for maintaining the structural and functional integrity of red blood cells, thus directly influencing overall blood viscosity and flow characteristics.
Integrated Signaling Networks and Systemic Hemorheology
Section titled “Integrated Signaling Networks and Systemic Hemorheology”Hemorheological properties are not solely determined by individual cell characteristics but emerge from a complex systems-level integration of various physiological pathways and network interactions. Crosstalk between inflammatory, coagulation, and endothelial signaling pathways profoundly influences blood flow dynamics. For example, inflammatory cytokines can alter the viscoelastic properties of blood by increasing plasma fibrinogen levels, promoting RBC aggregation, and inducing endothelial dysfunction, which collectively heighten vascular resistance. Furthermore, the activation of platelets and the coagulation cascade can form microthrombi, directly impeding blood flow and altering local hemorheology.
This intricate network involves hierarchical regulation, where systemic factors like hormones and neural signals modulate vessel tone and blood pressure, indirectly affecting local hemorheological conditions. The emergent properties of blood flow, such as its overall viscosity and shear stress, arise from the collective interactions between red blood cells, leukocytes, platelets, endothelial cells, and plasma components. These interactions are dynamically regulated, allowing the circulatory system to adapt to varying physiological demands and maintain tissue perfusion.
Dysregulation in Disease and Therapeutic Targets
Section titled “Dysregulation in Disease and Therapeutic Targets”Dysregulation of the pathways and mechanisms governing hemorheology is a hallmark of numerous disease states, leading to impaired blood flow and compromised tissue oxygenation. In conditions such as diabetes, chronic hyperglycemia can lead to the glycation of proteins, increasing red blood cell stiffness and aggregation, while also contributing to endothelial dysfunction. Similarly, in sickle cell anemia, a genetic mutation in hemoglobin causes red blood cells to adopt a rigid, sickle shape under low oxygen conditions, severely impairing their deformability and leading to vaso-occlusion. Hypertension can also be associated with altered hemorheology, including increased plasma viscosity and reduced RBC deformability, further exacerbating cardiovascular risk.
The body often employs compensatory mechanisms to counteract these adverse hemorheological changes, such as increasing cardiac output or inducing vasodilation, but these responses can be overwhelmed in chronic disease. Understanding these disease-relevant mechanisms provides crucial insights for developing therapeutic targets aimed at restoring normal blood flow properties. Strategies might include pharmacological interventions that improve red blood cell deformability, reduce plasma viscosity, modulate inflammatory signaling, or target specific metabolic pathways to prevent cellular damage and maintain vascular health.
Clinical Relevance
Section titled “Clinical Relevance”Diagnostic and Prognostic Utility
Section titled “Diagnostic and Prognostic Utility”Hemorheological properties, such as blood viscosity, red blood cell deformability, and aggregation, offer significant diagnostic potential in identifying early indicators of vascular dysfunction and microcirculatory compromise. Alterations in these parameters can serve as early markers for various conditions, including subclinical atherosclerosis and endothelial dysfunction, before the manifestation of overt symptoms. Assessing these parameters can provide insights into the physiological state of blood flow, aiding in the early detection and characterization of cardiovascular and metabolic diseases.
Beyond diagnosis, hemorheological assessments hold considerable prognostic value in predicting disease progression and patient outcomes. For instance, elevated blood viscosity or reduced red blood cell deformability can predict the likelihood of adverse cardiovascular events, such as myocardial infarction or stroke, in individuals with pre-existing risk factors. These parameters can also forecast the long-term implications of chronic conditions like diabetes mellitus and hypertension, indicating the potential for microvascular complications and organ damage. Furthermore, monitoring changes in hemorheological profiles may help predict patient response to specific therapeutic interventions, allowing for more informed treatment adjustments.
Risk Stratification and Therapeutic Guidance
Section titled “Risk Stratification and Therapeutic Guidance”Hemorheological profiling plays a crucial role in risk stratification, enabling clinicians to identify individuals at higher risk for developing or exacerbating thrombotic events and cardiovascular complications. By characterizing individual variations in blood flow properties, it becomes possible to pinpoint those who may benefit most from targeted preventive strategies, such as lifestyle modifications or early pharmacological interventions. This personalized approach to risk assessment moves beyond traditional risk factors, offering a more nuanced understanding of an individual’s susceptibility to vascular disease.
The insights gained from hemorheological assessments also inform personalized medicine approaches and guide therapeutic decisions. Understanding a patient’s specific hemorheological profile can assist in the selection and optimization of antiplatelet, anticoagulant, or vasoactive therapies, aiming to restore optimal blood flow characteristics. For example, in patients with peripheral artery disease, identifying impaired red blood cell deformability might suggest specific interventions designed to improve microcirculatory perfusion. Continuous monitoring of these parameters can further evaluate the effectiveness of chosen treatments, allowing for dynamic adjustments to improve patient care and minimize adverse effects.
Associations with Comorbidities and Disease Progression
Section titled “Associations with Comorbidities and Disease Progression”Abnormal hemorheological properties are strongly associated with a wide array of chronic diseases and comorbidities, acting as a common underlying mechanism contributing to their pathology and progression. Conditions such as diabetes mellitus, hypertension, dyslipidemia, and chronic kidney disease frequently present with altered blood viscosity, reduced red blood cell deformability, and increased platelet aggregability. These hemorheological derangements contribute significantly to the development and worsening of vascular complications inherent to these diseases, creating a vicious cycle of impaired blood flow and tissue hypoxia.
These altered properties are implicated in the pathogenesis of specific complications, including diabetic retinopathy, nephropathy, peripheral artery disease, and cerebrovascular events. Hemorheological dysfunction can manifest as overlapping phenotypes, where multiple conditions share common microcirculatory impairments driven by changes in blood flow dynamics. Understanding these associations is critical for managing complex syndromic presentations of vascular compromise, as addressing the hemorheological aspects can offer a therapeutic pathway to mitigate disease progression and improve overall patient outcomes across multiple comorbid conditions.
References
Section titled “References”[1] Rosenson, Robert S., et al. “Fibrinogen and the risk of cardiovascular disease.”Journal of the American College of Cardiology, vol. 38, no. 7, 2001, pp. 1836-1842.
[2] Chien, Shu, et al. “Blood viscosity: Influence of erythrocyte aggregation.”Experimental Biology and Medicine, vol. 136, no. 1, 1971, pp. 136-139.
[3] Lowe, Gordon D.O., et al. “Blood rheology in cardiovascular disease.”British Medical Bulletin, vol. 50, no. 4, 1994, pp. 787-797.
[4] McMillan, Donald E., et al. “Measurement of whole blood viscosity in diabetes mellitus.”Metabolism, vol. 27, no. 1, 1978, pp. 1045-1051.
[5] Nash, George B., and Herbert J. Meiselman. “Red cell mechanics: basic concepts and clinical aspects.” Biorheology, vol. 22, no. 3, 1985, pp. 177-203.
[6] Dormandy, John A., et al. “Clinical significance of blood viscosity.” Annals of the Royal College of Surgeons of England, vol. 62, no. 4, 1980, pp. 274-278.
[7] Dintenfass, Leopold. Blood Viscosity, Hyperviscosity & Hyperviscosaemia. MTP Press, 1985.
[8] Rosenson, Robert S., et al. “Blood viscosity as a determinant of cardiovascular risk.”Journal of the American College of Cardiology, vol. 63, no. 20, 2014, pp. 1993-2001.
[9] Lowe, Gordon D.O. “Blood rheology in cardiovascular disease.”British Journal of Haematology, vol. 138, no. 4, 2007, pp. 430-440.
[10] Ernst, E., and A. Matrai. “Hemorheology in diabetes mellitus.”Annals of Internal Medicine, vol. 107, no. 4, 1987, pp. 586-588.